Close Menu

Waters

The company's Life Sciences Group reported $431 million in revenues, with all platforms posting double-digit sales increases including a 21-percent rise in liquid chromatography sales led by the strong performance of the 1290 and 1260 Infinity LC lines.

Movers & Shakers

Premium

Marten Winge, Jeremy Nicholson, John Engen, James Scrivens, Julie Leary

In a third quarter earnings call, CEO Douglas Berthiaume said growing demand for the Acuity H-Class UPLC platform helped drive a 9-percent rise in instrument sales year over year, while total receipts increased 9 percent and profit widened 25 percent.

Despite a soft government spending market in Western Europe, continued adoption of the company's Acquity UPLC H-Class instrument and high-end mass specs paced revenue growth.

Agilent, Waters, and Danaher in particular noted a number of recently released mass spectrometry and liquid chromatography platforms as being significant drivers of sales growth.

This week executives from several firms in the molecular research tools and molecular diagnostics fields made their pitch to investors at the annual UBS Global Life Sciences Conference.

New Products

Premium

BAC, Gentel Biosciences, Phoenix S&T, Waters

Waters expects the deal to result in its products being offered to a broader use base.

As the current earnings season draws to a close, much of the talk from life science tool firms focused on the technologies they view as key revenue drivers now and going forward. Not surprisingly, sequencing, PCR, and mass spec were cited by the big research tool firms.

A Waters' official said the company's mass spec business was its "strongest performer across the line," while Bruker touted healthy growth in revenues and new orders in life sciences mass spec.

Pages

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.